WeLeader Biomedical Co Stock

WeLeader Biomedical Co P/CF

The P/CF (Price-to-Cash-Flow Ratio) of WeLeader Biomedical Co (7713.TWO) as of Aug 16, 2026 is 10.31. In the previous year, P/CF (Price-to-Cash-Flow Ratio) was 11.58 — a change of -11.02% (lower).

P/CF

10.31

YoY

-11.02%

Last updated:

P/CF (Price-to-Cash-Flow Ratio) of WeLeader Biomedical Co is 2026 10.31 . P/CF (Price-to-Cash-Flow Ratio) of WeLeader Biomedical Co was 2025 11.58 . It decreases by -11.02% lower compared to the previous year.
Access this data via the Eulerpool API

WeLeader Biomedical Co Stock analysis

What does WeLeader Biomedical Co do? WeLeader Biomedical Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about WeLeader Biomedical Co stock

P/CF (Price-to-Cash-Flow Ratio) of WeLeader Biomedical Co is 10.31 in 2026.

P/CF (Price-to-Cash-Flow Ratio) of WeLeader Biomedical Co changed from 11.58 to 10.31, representing a -11.02% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of P/CF (Price-to-Cash-Flow Ratio) WeLeader Biomedical Co since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Cash-Flow ratio measures the stock price relative to operating cash flow per share. Unlike P/E, it is harder to manipulate as cash flow is less subject to accounting adjustments.

P/CF = Stock Price / Operating Cash Flow per Share

To evaluate P/CF (Price-to-Cash-Flow Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/CF (Price-to-Cash-Flow Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/CF (Price-to-Cash-Flow Ratio)'s WeLeader Biomedical Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — WeLeader Biomedical Co

All Key Metrics — WeLeader Biomedical Co